Wang Wenyu, Zhao Guoqiang, Zhou Yun, Fan Hongkun, Wu Gang
Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430023, China.
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi. 2013 Feb;30(1):131-5.
The lentiviral vector was used for construction of a recombinant mediating RNA interference (RNAi) against Beclin1 gene in this study. Recombinant vector plasmid was transfected into non small cell lung cancer (NSCLC) A549 cells by liposome. PCR results showed that three amplified positive fragments were inserted into pRNAT-U6. 2/Lenti vectors. DNA sequencing results showed that the three recombinant lentivirus plasmids, pRNAT-U6. 2/Lenti-si356, pRNAT-U6. 2/Lenti-si423 and pRNAT-U6. 2/ Lenti-si684 were constructed successfully. After transfection with liposome, RT-PCR and Western blot analysis confirmed that the expression of Beclin1 mRNA and protein was inhibited in the three recombinant lentivirus plasmids transfected groups, and gene silencing efficacy was 35.56%, 89.22% and 66.78%, respectively. The results demonstrated that the lentiviral vectors of RNAi targeting Beclin1 gene were successfully constructed, and NSCLC A549 stable cell line with Beclin1 gene knockdown was established. This study finally provided a new cell model to explore the biological behavior of the Beclin1 gene in NSCLC A549 cells.
本研究使用慢病毒载体构建针对Beclin1基因的重组RNA干扰(RNAi)介导物。通过脂质体将重组载体质粒转染至非小细胞肺癌(NSCLC)A549细胞中。PCR结果显示,三个扩增的阳性片段插入到pRNAT-U6.2/Lenti载体中。DNA测序结果表明,成功构建了三种重组慢病毒质粒,即pRNAT-U6.2/Lenti-si356、pRNAT-U6.2/Lenti-si423和pRNAT-U6.2/Lenti-si684。脂质体转染后,RT-PCR和蛋白质印迹分析证实,在三种重组慢病毒质粒转染组中,Beclin1 mRNA和蛋白质的表达受到抑制,基因沉默效率分别为35.56%、89.22%和66.78%。结果表明,成功构建了靶向Beclin1基因的RNAi慢病毒载体,并建立了Beclin1基因敲低的NSCLC A549稳定细胞系。本研究最终提供了一个新的细胞模型,用于探索Beclin1基因在NSCLC A549细胞中的生物学行为。